ST-segment deviation or troponin elevation of patients with acute chest pain without testing and circulating biomarkers for evaluation Combination of clinical risk profile , early exercise

[1]  J. Núñez,et al.  A practical approach with outcome for the prognostic assessment of non-ST-segment elevation chest pain and normal troponin. , 2007, The American journal of cardiology.

[2]  J. Ware.  The limitations of risk factors as prognostic tools. , 2006, The New England journal of medicine.

[3]  N. Nagajothi,et al.  Biomarkers in acute cardiac disease. , 2006, Journal of the American College of Cardiology.

[4]  J. Núñez,et al.  Prognostic usefulness of white blood cell count on admission and one-year outcome in patients with non-ST-segment elevation acute chest pain. , 2006, The American journal of cardiology.

[5]  Fred S Apple,et al.  Biomarkers in acute cardiac disease: the present and the future. , 2006, Journal of the American College of Cardiology.

[6]  Vicente Bertomeu-González,et al.  Usefulness of early exercise testing and clinical risk score for prognostic evaluation in chest pain units without preexisting evidence of myocardial ischemia. , 2006, The American journal of cardiology.

[7]  K. Pettersson,et al.  Immunoassays developed for pregnancy-associated plasma protein-A (PAPP-A) in pregnancy may not recognize PAPP-A in acute coronary syndromes. , 2006, Clinical chemistry.

[8]  J. Tijssen,et al.  Dynamics in N-terminal pro-brain natriuretic peptide concentration in patients with non-ST-elevation acute coronary syndrome. , 2005, American heart journal.

[9]  J. Núñez,et al.  New risk score for patients with acute chest pain, non-ST-segment deviation, and normal troponin concentrations: a comparison with the TIMI risk score. , 2005, Journal of the American College of Cardiology.

[10]  J. Núñez,et al.  Risk stratification of patients with acute chest pain and normal troponin concentrations , 2005, Heart.

[11]  C. Heeschen,et al.  Pregnancy-associated plasma protein-A levels in patients with acute coronary syndromes: comparison with markers of systemic inflammation, platelet activation, and myocardial necrosis. , 2005, Journal of the American College of Cardiology.

[12]  H. White,et al.  N-Terminal Pro–B-Type Natriuretic Peptide Levels for Dynamic Risk Stratification of Patients With Acute Coronary Syndromes , 2004, Circulation.

[13]  L. Sokoll,et al.  Evaluation of pregnancy-associated plasma protein A as a prognostic indicator in acute coronary syndrome patients. , 2004, Clinica chimica acta; international journal of clinical chemistry.

[14]  D. Ardissino,et al.  N-Terminal Pro-Brain Natriuretic Peptide on Admission Has Prognostic Value Across the Whole Spectrum of Acute Coronary Syndromes , 2004, Circulation.

[15]  V. Bodí,et al.  [Relationship of C-reactive protein levels with angiographic findings and markers of necrosis in non-ST-segment elevation acute coronary syndrome]. , 2004, Revista espanola de cardiologia.

[16]  K. Eagle,et al.  Elevated leukocyte count and adverse hospital events in patients with acute coronary syndromes: findings from the Global Registry of Acute Coronary Events (GRACE). , 2004, American heart journal.

[17]  E. Topol,et al.  Prognostic value of myeloperoxidase in patients with chest pain. , 2003, The New England journal of medicine.

[18]  P. Porela,et al.  Circulating Pregnancy-Associated Plasma Protein A Predicts Outcome in Patients With Acute Coronary Syndrome but No Troponin I Elevation , 2003, Circulation.

[19]  E. Amsterdam,et al.  Immediate Exercise Testing to Evaluate Low-Risk Patients Presenting to the Emergency Department with Chest Pain. , 2003 .

[20]  M. Sabatine,et al.  Evaluation of B-type natriuretic peptide for risk assessment in unstable angina/non-ST-elevation myocardial infarction: B-type natriuretic peptide and prognosis in TACTICS-TIMI 18. , 2003, Journal of the American College of Cardiology.

[21]  B. Lindahl,et al.  N-terminal pro brain natriuretic peptide on admission for early risk stratification of patients with chest pain and no ST-segment elevation. , 2002, Journal of the American College of Cardiology.

[22]  Michael R Cusack,et al.  Systemic inflammation in unstable angina is the result of myocardial necrosis. , 2002, Journal of the American College of Cardiology.

[23]  Nader Rifai,et al.  Multimarker Approach to Risk Stratification in Non-ST Elevation Acute Coronary Syndromes: Simultaneous Assessment of Troponin I, C-Reactive Protein, and B-Type Natriuretic Peptide , 2002, Circulation.

[24]  D. Morrow,et al.  The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes☆ , 2002 .

[25]  K. Pettersson,et al.  Release Patterns of Pregnancy Associated Plasma Protein A (PAPP-A) in Patients with Acute Coronary Syndromes , 2002, Scandinavian cardiovascular journal : SCJ.

[26]  M. Runge,et al.  Randomized comparison of a strategy of predischarge coronary angiography versus exercise testing in low-risk patients in a chest pain unit: in-hospital and long-term outcomes. , 2001, Journal of the American College of Cardiology.

[27]  J S Alpert,et al.  Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. , 2000, Journal of the American College of Cardiology.

[28]  C. Camargo,et al.  Effect of leukocytosis at initial examination on prognosis in patients with primary unstable angina. , 2000, American heart journal.

[29]  J R Roelandt,et al.  Safety and prognostic value of early dobutamine-atropine stress echocardiography in patients with spontaneous chest pain and a non-diagnostic electrocardiogram. , 2000, European heart journal.

[30]  I. Universitari.  Multimarker risk strategy for predicting 1- month and 1- year major events in non- ST- elevation acute coronary syndromes , 2005 .

[31]  J. Núñez,et al.  [Emergency room risk stratification of patients with chest pain without ST segment elevation]. , 2003, Revista espanola de cardiologia.